← Evidence map

ArticleCancer medicine2024

Real world data of cabozantinib in patients with hepatocellular carcinoma: Focusing on dose setting and modification.

Hironao Okubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39315523